08:50 AM EDT, 08/20/2024 (MT Newswires) -- Michael Andrew Chambers, Director, on August 16, 2024, executed a purchase for 37,038 shares in Sarepta Therapeutics ( SRPT ) for $4,955,728. Following the Form 4 filing with the SEC, Chambers has control over a total of 292,311 shares of the company, with 8,277 shares held directly and 284,034 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/873303/000095017024098859/xslF345X03/ownership.xml

Price: 139.64, Change: +2.36, Percent Change: +1.72